NORTHBROOK, Ill.–(BUSINESS WIRE)–UL Solutions (NYSE: ULS), a global leader in applied safety science, issued a public notice regarding Protech International carbon monoxide detectors, product model PTH-24D, which bear unauthorized UL Certification Marks and may pose safety risks. These products, sold under the brand name LSENLTY through Amazon.com, have not been evaluated by UL Solutions to the appropriate safety standards, and it is unknown whether they meet any safety requirements. UL Solut
Month: September 2026
NORTHBROOK, Ill.–(BUSINESS WIRE)–UL Solutions (NYSE: ULS), líder mundial en ciencias de seguridad aplicadas, emitió un aviso público con respecto a detectores de monóxido de carbono Protech International, modelo de producto PTH‑24D, los cuales llevan marcas de certificación UL no autorizadas y pueden representar riesgos de seguridad. Estos productos, vendidos bajo la marca LSENLTY a través de Amazon.com, no han sido evaluados por UL Solutions según las normas de seguridad adecuadas, y se desc
DENVER–(BUSINESS WIRE)–Lumen Technologies, Inc. (“Lumen,” “us,” “we,” or “our”) (NYSE: LUMN) today announced that its Board of Directors has approved the voluntary transfer of the listing of Lumen’s common stock, as well as the 6.500% Notes due 2051 (CTGG) and 6.750% Notes due 2052 (CTHH) issued by its wholly owned subsidiary, Qwest Corporation (the “Securities”), from the New York Stock Exchange (“NYSE”) to The Nasdaq Stock Market LLC (“Nasdaq”). Lumen and Qwest Corporation have filed applic
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present new data from its portfolio of treatments for Duchenne muscular dystrophy at the 31st Annual Congress of the World Muscle Society (WMS), taking place Sept. 29 – Oct. 3, in Hiroshima, Japan. Data at WMS includes a late-breaking poster presentation on delandistrogene moxeparvovec efficacy and safety in older, ambulatory Duchenne patients in Sarepta’
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best will sponsor and exhibit at the Association of Insurance Compliance Professionals (AICP) Annual Conference at the Louisville Marriott Downtown in Kentucky, Oct. 10–13, 2026. Join Director of Product Strategy Scott Jordan and Managers John Czuba and Matt Radman to learn more about the resources AM Best offers to insurance professionals, including:Best’s State Rate Filings®: Keep up with U.S. property/casualty and life/health program innovations, find out wh
COLUMBUS, Ohio–(BUSINESS WIRE)–McGraw Hill, Inc. (the “Company”) announced today that McGraw-Hill Education, Inc., the Company’s wholly-owned subsidiary (the “Issuer”) intends, subject to market conditions, to offer $500 million in aggregate principal amount of senior secured notes due 2033 (the “Notes”) in a private offering (the “Offering”). The Notes will be guaranteed by the Issuer’s parent, Mav Intermediate Holding II Corporation, and certain of the Issuer’s direct and indirect subsidiar
LONDON–(BUSINESS WIRE)– FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be
LONDON–(BUSINESS WIRE)– FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be
LONDON–(BUSINESS WIRE)– FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be
LONDON–(BUSINESS WIRE)– FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be